Nitric oxide, iron complexes

Szacilowski K, Chmura A, Stasicka Z. Interplay between iron complexes, nitric oxide and sulfur ligands Structure, (photo)reactivity and biological importance. Coord Chem Rev 2005 249 2408-36. 

Keese MA, Bose M et al (1997) Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase. Biochem Pharmacol 54 1307-1313... 

Nitric oxide rapidly reacts with transition metals, which have stable oxidation states differing by one electron (see Chapters 2 and 3). Nitric oxide is unusual in that it reacts with both the ferric (Fe " ) and ferrous forms (Fe " ) of iron. TTie unpaired electron of nitric oxide is partially transferred to the metal forming a principally ionic bond. Complexes of ferric iron with nitric oxide are called nitrosyl compounds and will nitrosate (add an NO group) many compounds, while reducing the iron to the ferrous state (Wade and Castro, 1990). 

But, because there was also a first-order term, reduction via a dinitrosyl complex may not be compulsory. It is doubtful that cytochromes could participate in NO reduction via dinitrosyl complexes, because of strong axial coordination of Fe by at least one protein ligand. It is of course possible that the nonheme iron of nitric oxide reductase is the actual site of reduction of NO. 

Nitric Oxide Halide Complexes. The dimeric diamagnetic halides [Fe(NO)2X]2 have essentially tetrahedrally coordinated iron atoms with bridging halides. The trinitrosyl halides [Fe(NO)3X] are comparatively much less stable they can be prepared by the reaction of [Fe(CO)2X]2 with iron and nitric oxide. The complexes [Fe(NO)X3] and [Fe(NO)2X2] are known but much more work has been done on the reactivity of the dimeric dinitrosyl, and some of its reactions are illustrated in Scheme 2. 

Chiou YM, Que J (1995) Model studies of a-keto acid-dependent nonheme iron enzymes nitric oxide adducts of [Fe (L)(02CCOPh)] (CIO4) complexes. Inorg Chem 34 3270-3278... 

Water soluble iron porphyrins [Fem(TPPS)(H20) ]3-330 and [Fem(TMPy)(H20)2]5+ 331 332 (TPPS = maso-tetrakis(/ -sulfonatophenyl)porphyrin, TMPyP = / /e.vo-tetrakis(7V-methyl-4-pyridi-nium)porphyrin331 or maso-tetrakis (A -methyl-2-pyridinium)porphyrin332 dications) act as effective electrocatalysts for the reduction of nitrite to ammonia in aqueous electrolytes (Equation (64) Ei/2= 0.103 V vs. SCE at pH 7), with NH2OH or N20 also appearing as products depending on the reaction conditions. Nitric oxide then ligates to the iron(III) porphyrin to form a nitrosyl complex [Fen(P)(NO+)] (P = porphyrin) as intermediate. 

The iron complex (23) adsorbed on graphite electrode surfaces is an active catalyst for the electroreduction of both nitrite and nitric oxide to yield NH2OH and NH3, as demonstrated by rotating ring-disk electrode voltammetry experiments.341... 

The formation of nitric oxide in microsomes results in the inhibition of microsomal reductase activity. It has been found that the inhibitory effect of nitric oxide mainly depend on the interaction with cytochrome P-450. NO reversibly reacts with P-450 isoforms to form the P-450-NO complex, but at the same time it irreversibly inactivates the cytochrome P-450 via the modification of its thiol residues [64]. Incubation of microsomes with nitric oxide causes the inhibition of 20-HETE formation from arachidonic acid [65], the generation of reactive oxygen species [66], and the release of catalytically active iron from ferritin [67],... 

The NO/NO+ and NO/NO- self-exchange rates are quite slow (42). Therefore, the kinetics of nitric oxide electron transfer reactions are strongly affected by transition metal complexes, particularly by those that are labile and redox active which can serve to promote these reactions. Although iron is the most important metal target for nitric oxide in mammalian biology, other metal centers might also react with NO. For example, both cobalt (in the form of cobalamin) (43,44) and copper (in the form of different types of copper proteins) (45) have been identified as potential NO targets. In addition, a substantial fraction of the bacterial nitrite reductases (which catalyze reduction of NO2 to NO) are copper enzymes (46). The interactions of NO with such metal centers continue to be rich for further exploration. 

Manganese nitrosyl porphyrins [215] are considered good models for the iron-nitric oxide analogs, which are relatively unstable but very vital to many biological operations. A six-coordinate manganese nitrosyl porphyrin of the form (por)Mn(NO)(L), where por can be TTP (TTP = tetra(4-methylphenyl)porphine) and L = piperidine, methanol, 1-methyhmidazole, has been prepared [216] in moderate yields by the reductive nitrosylation of the (por)MnCl complex with NO in piperidine. The crystal structures of these compounds give indication of a linear Mn-NO bond [215]. 

Despite intense study of the chemical reactivity of the inorganic NO donor SNP with a number of electrophiles and nucleophiles (in particular thiols), the mechanism of NO release from this drug also remains incompletely understood. In biological systems, both enzymatic and non-enzymatic pathways appear to be involved [28]. Nitric oxide release is thought to be preceded by a one-electron reduction step followed by release of cyanide, and an inner-sphere charge transfer reaction between the ni-trosonium ion (NO+) and the ferrous iron (Fe2+). Upon addition of SNP to tissues, formation of iron nitrosyl complexes, which are in equilibrium with S-nitrosothiols, has been observed. A membrane-bound enzyme may be involved in the generation of NO from SNP in vascular tissue [35], but the exact nature of this reducing activity is unknown. 

The therapeutic effects of sodium nitroprusside depend on release of nitric oxide which relaxes vascular muscle. Sodium nitroprusside is best formulated as a nitrosonium (NO+) complex. Its in vivo activation is probably achieved by reduction to [Fe(CN)5NO]3, which then releases cyanide to give [Fe(CN)4NO]2, which in turn releases nitric oxide and additional CN to yield aquated Fe(II) species and [Fe(CN)6]4 (502). There are problems associated with its use, namely reduced activity due to photolysis (501) and its oxidative breakdown due to the action of an activated immune system (503), both of which release cyanide from the low-spin d6 iron complex. 

Clearly the molecular events with iron were complex even at 80 K and low NO pressure, and in order to unravel details we chose to study NO adsorption on copper (42), a metal known to be considerably less reactive in chemisorption than iron. It was anticipated, by analogy with carbon monoxide, that nitric oxide would be molecularly adsorbed on copper at 80 K. This, however, was shown to be incorrect (43), and by contrast it was established that the molecule not only dissociated at 80 K, but NjO was generated catalytically within the adlayer. On warming the adlayer formed at 80 K to 295 K, the surface consisted entirely of chemisorbed oxygen with no evidence for nitrogen adatoms. It was the absence of nitrogen adatoms [with their characteristic N(ls) value] at both 80 and 295 K that misled us (43) initially to suggest that adsorption was entirely molecular at 80 K. 

In summary, there is still much to understand about the nitrite reduction reaction. The crystal structures have shown how nitrite can bind to the di heme iron and protons can be provided to one of its oxygen atoms from two histidine residues. However, as yet no rapid reaction study has detected the release of product nitric oxide rather than the formation of the inhibitory dead-end ferrous di heme-NO complex. It is also not clear why the rate of interheme electron transfer is so slow over 11 A when nitrite or nitric oxide is the ligand to the d heme. 

Fe(CN)5(NO)] makes several appearances in a recent symposium volume dedicated to nitric oxide in biosystems, for example in cormection with iron(II) dtrate-induced oxidative stress." " Nitroprusside is the only metal nitrosyl complex in clinical use, where it is important as a rapidly acting agent for the lowering of exceptionally high blood pressure. ... 

---